Medical Communications

Showing 15 posts of 6402 posts found.

Allergan sues Pfizer over opioid crisis lawsuits

August 3, 2018 Medical Communications Allergan, Litigation, Pfizer, lawsuits, opioid crisis, opioids

Allergan are suing American pharma giant Pfizer over potential damages that they may be forced to pay relating to hundreds …

Computer simulations predict spread of HIV

August 3, 2018 Medical Communications

Researchers at the Los Alamos National Laboratory have developed a computer simulation that is able to accurately predict the transmission …
usmarinetankinbaghdad

Lawsuit alleges pharma giants funded terror in Iraq

August 2, 2018 Business Services, Medical Communications, Sales and Marketing AstraZeneca, Iraq War, J&J, JJ, Litigation, Roche, corruption, terrorism

The United States Justice Department is investigating claims that major pharmaceutical and medical device companies were aware that supplies that …
ema_logo

EMA to cut activities as it forecasts loss of 30% of staff

August 2, 2018 Medical Communications, Research and Development EMA, London, UK, amsterdam, brexit, disruption, staff

The European Medicines Agency is set to enact temporary cuts in activities as it prepares for significant disruption in the …
rowa_vmax

Biosimilars and generics saved NHS £324m last year

August 2, 2018 Medical Communications, Sales and Marketing Cancer, NHS, biosimilars, funding, generics

The NHS watchdog, NHS Improvement, has revealed that the British National Health Service saved £324 million last financial year by …
john-milligan-thumbnail-300x300

Gilead’s CEO and Chairman to both step down before year’s end

July 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …

Living with Behçet’s disease

July 30, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Behçet's disease, patient experience, pharma

Suzanne Morris speaks to Pharmafocus to discuss her life with Behçet’s disease, a rare condition characterised by the inflammation of …
sean-harper

Amgen announces resignation of two top executives

July 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Anthony C Cooper, R&D, biotech, retire, sean harper

Amgen’s head of R&D, Dr Sean Harper, has announced that he is retiring from his current position as Executive Vice …
32514377531_3583dbc34b_z

Those at risk of HIV to be offered PrEP drugs in England and Northern Ireland

July 27, 2018 Medical Communications AIDS, England, HIV, PrEP, Terrence Higgins Trust

Those at risk of contracting HIV will now be offered PrEP drugs in England and Northern Ireland through a programme …
takeda_usa_pharmaceuticals_u

Takeda’s Alunbrig topples Pfizer’s Xalkori in ALK-positive lung cancer

July 27, 2018 Medical Communications, Research and Development Alunbrig, Cancer, NSCLC, Pfizer, Takeda, Xalkori, lung cancer, pharma

Takeda has unveiled new Phase 3 data showing that its tyrosine kinase inhibitor (TKI) Alunbrig (brigatinib) not only met its …
Canary Wharf European Medicines Agency

Landlord demands EMA pay £500m for Canary Wharf lease

July 27, 2018 Medical Communications Canary Wharf, EMA, Litigation, London, amsterdam, court

A British landlord is taking the European Medicines Agency (EMA) to court over a £500 million bill for unpaid rent. …
Scientist looking at medicinal cannabis in a laboratory

Cannabis-derived medicinal products to become available in UK

July 26, 2018 Medical Communications cannabis, law, medicinal marijuana, prescription, sajid javid, schedule drugs, uk politics

Home Secretary Sajid Javid has announced that cannabis derived medicinal products will be made available on prescription “by the autumn” …

Gilead’s CEO and Chairman to both step down before year’s end

July 26, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its President and Chief Executive Officer Dr John Milligan (pictured) will be stepping down by the …
The Gateway to Local Adoption Series

Latest content